Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue EBioMedicine Année : 2023

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms

Dates et versions

hal-04204691 , version 1 (12-09-2023)

Identifiants

Citer

Jérémy Ariey-Bonnet, Raphael Berges, Marie-Pierre Montero, Baptiste Mouysset, Patricia Piris, et al.. Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms. EBioMedicine, 2023, 95, pp.104752. ⟨10.1016/j.ebiom.2023.104752⟩. ⟨hal-04204691⟩
14 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More